24/7 Market News Snapshot- Sharps Technology (NASDAQ: STSS)

Press Release

DENVER, Colo., 13 June, 2024 (247marketnews.com)- The stock market is abuzz with the pre-market surge of Sharps Technology (NASDAQ:STSS), currently trading at $0.371 with a substantial 23.91% increase from yesterday’s market close. With a trading volume of 5.0M shares and a promising uptrend, investors are eyeing a lucrative opportunity to capitalize on this positive momentum. Meanwhile, in the medical supply industry, industry giants Sharps and Nephron have finalized a momentous five-year, $200 million Syringe Sales Agreement, solidifying their collaboration.

The Purchase Order agreement ensures a consistent procurement of syringe products for the initial 12-month period, with prefillable syringe shipments expected to begin in the second quarter of 2025. This strategic partnership highlights the companies’ dedication to meeting the increasing demands of the healthcare sector and reinforces their market position.

By securing this significant agreement, Sharps and Nephron are poised for growth and enhanced market competitiveness, setting the stage for future success. The collaboration showcases a commitment to innovation and excellence in providing essential medical supplies, signaling a positive trajectory for both companies in the industry. Industry stakeholders eagerly anticipate the outcomes of this partnership and the impact it will have on shaping the future of medical supply provision.

About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.

24/7 Market News, Inc Disclaimer
Please go to https://247marketnews.com/disclaimer/ for disclaimer information.

CONTACT:
24/7 Market News
Editor@247marketnews.com

Related news for (STSS)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.